# Bioinformatics Analysis of Genes Associated with Autophagy and Metabolic Reprogramming in Atrial Fibrillation

**Authors:** Yaqianqian Niu, Kensuke Ihara, Satoshi Iwamiya, Tetsuo Sasano

PMC · DOI: 10.3390/jcdd13020082 · 2026-02-08

## TL;DR

This study explores how genes related to autophagy and metabolic changes behave in atrial fibrillation, using human and mouse data to identify key genes involved in the condition.

## Contribution

The study identifies eight key genes linked to autophagy and metabolic reprogramming in atrial fibrillation using cross-species analysis.

## Key findings

- Eight differentially expressed genes were identified as key candidates in autophagy and metabolic reprogramming in atrial fibrillation.
- AKT1 and HSPA5 showed consistent expression changes in both human and mouse atrial tissues, suggesting their role in AF pathogenesis.
- GLUD1 exhibited discordant regulation between human and mouse models, indicating species-specific differences.

## Abstract

Atrial fibrillation (AF) is the most common cardiac arrhythmia, and both metabolic reprogramming and autophagy have been implicated in its pathogenesis. However, the expression pattern of autophagy-related genes during metabolic reprogramming in AF remains elusive. We aimed to characterize the expression profiles of autophagy- and metabolic reprogramming-related genes in atrial tissue to gain pathophysiological insights into AF. Three datasets obtained from the Gene Expression Omnibus (GSE2240, GSE79768, and GSE14975) that included atrial tissue samples from patients with or without AF were subjected to a bioinformatics analysis, which identified 2812 differentially expressed genes. Eight autophagy- and metabolic reprogramming-related differentially expressed genes (A&MRRDEGs) were identified as key candidates through least absolute shrinkage and selection operator regression combined with the random forest approach. Meanwhile, mice underwent transverse aortic constriction (TAC) for 2 weeks in an AF model, and gene expression in atrial tissue was analyzed. In atrial tissues from TAC mice, only Akt1 and Hspa5 of the eight A&MRRDEGs exhibited expression changes concordant with the human datasets, while Glud1 showed discordant regulation. Collectively, these cross-species findings highlight that the eight A&MRRDEGs, particularly AKT1 and HSPA5, are potentially involved in autophagy and metabolic reprogramming during AF pathogenesis.

## Linked entities

- **Genes:** AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207], HSPA5 (heat shock protein family A (Hsp70) member 5) [NCBI Gene 3309], GLUD1 (glutamate dehydrogenase 1) [NCBI Gene 2746]
- **Diseases:** atrial fibrillation (MONDO:0004981)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Notch1 (notch 1) [NCBI Gene 18128] {aka 9930111A19Rik, Mis6, N1, Tan1, lin-12}, YWHAQ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta) [NCBI Gene 10971] {aka 14-3-3, 1C5, HS1}, Hspa5 (heat shock protein family A (Hsp70) member 5) [NCBI Gene 14828] {aka Bip, D2Wsu141e, D2Wsu17e, Grp78, Hsce70, SEZ-7}, Itpr3 (inositol 1,4,5-triphosphate receptor 3) [NCBI Gene 16440] {aka IP3R 3, IP3R-3, Ip3r3, Itpr-3, tf}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, COXFA4L2 (cytochrome c oxidase hypoxia associated subunit FA4L2) [NCBI Gene 56901] {aka MISTRH, NDUFA4L2, NUOMS}, Nsdhl (NAD(P) dependent steroid dehydrogenase-like) [NCBI Gene 18194] {aka Bpa, H105E3, Str, XAP104}, HSPA5 (heat shock protein family A (Hsp70) member 5) [NCBI Gene 3309] {aka BIP, GRP78, HEL-S-89n}, Glud1 (glutamate dehydrogenase 1) [NCBI Gene 14661] {aka Gdh-X, Glud, Gludl}, GLUD1 (glutamate dehydrogenase 1) [NCBI Gene 2746] {aka GDH, GDH1, GLUD, hGDH1}, Arpc4 (actin related protein 2/3 complex, subunit 4) [NCBI Gene 68089] {aka 20kDa, 5330419I20Rik, p20-Arc}, Mapk1 (mitogen-activated protein kinase 1) [NCBI Gene 26413] {aka 9030612K14Rik, ERK, Erk2, MAPK2, PRKM2, Prkm1}, TOMM22 (translocase of outer mitochondrial membrane 22) [NCBI Gene 56993] {aka 1C9-2, MST065, MSTP065, TOM22}, RTN4 (reticulon 4) [NCBI Gene 57142] {aka ASY, NI220/250, NOGO, NOGOA, NOGOB, NSP}, Pgm2 (phosphoglucomutase 2) [NCBI Gene 66681] {aka 3230402E02Rik, Pgm-1, Pgm1}, Pin1 (peptidyl-prolyl cis/trans isomerase, NIMA-interacting 1) [NCBI Gene 23988] {aka 0610025L01Rik, D9Bwg1161e}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, ARPC4 (actin related protein 2/3 complex subunit 4) [NCBI Gene 10093] {aka ARC20, DEVLO, P20-ARC}, SLC25A5 (solute carrier family 25 member 5) [NCBI Gene 292] {aka 2F1, AAC2, ANT2, T2, T3}, MFN1 (mitofusin 1) [NCBI Gene 55669] {aka hfzo1, hfzo2}, P4HA1 (prolyl 4-hydroxylase subunit alpha 1) [NCBI Gene 5033] {aka P4HA}, VDAC1 (voltage dependent anion channel 1) [NCBI Gene 7416] {aka PORIN, VDAC-1}, HSPA4 (heat shock protein family A (Hsp70) member 4) [NCBI Gene 3308] {aka APG-2, HEL-S-5a, HS24/P52, HSPH2, RY, hsp70}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, PGM1 (phosphoglucomutase 1) [NCBI Gene 5236] {aka CDG1T, GSD14}, Vdac1 (voltage-dependent anion channel 1) [NCBI Gene 22333] {aka Vdac5, mVDAC1, mVDAC5}
- **Diseases:** cardiac disorders (MESH:D006331), atrial enlargement (MESH:D006332), SR (MESH:C563907), breast cancer (MESH:D001943), heart failure (MESH:D006333), TAC (MESH:D009188), ARGs (MESH:C564093), weight loss (MESH:D015431), AF (MESH:D001281), cardiovascular diseases (MESH:D002318), myocardial infarction (MESH:D009203), stroke (MESH:D020521), obesity (MESH:D009765), cardiac arrhythmia (MESH:D001145), Cervical dislocation (MESH:D002575), arrhythmic atrial contractions (MESH:D018880), respiratory distress (MESH:D012128), Metabolic disorders (MESH:D008659), metabolic disturbances (MESH:D024821), atrial fibrosis (MESH:D005355), inflammatory (MESH:D007249), injury to (MESH:D014947), cancer (MESH:D009369), diabetes mellitus (MESH:D003920)
- **Chemicals:** purine (MESH:C030985), lipid (MESH:D008055), reactive oxygen species (MESH:D017382), glucose (MESH:D005947), GSVA (-), ribose phosphate (MESH:C031626), isoflurane (MESH:D007530), capivasertib (MESH:C575618), tricarboxylic acid (MESH:D014233)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** glutamine/glutamate, (TAC) for 2

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12942172/full.md

---
Source: https://tomesphere.com/paper/PMC12942172